Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer–Specific Outcomes: Results from the SEARCH Database-Reference-Cited by-同舟云学术

Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer–Specific Outcomes: Results from the SEARCH Database

Published:2014-03 Issue:3 Volume:65 Page:620-627
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Keto Christopher J.,Aronson William J.,Terris Martha K.,Presti Joseph C.,Kane Christopher J.,Amling Christopher L.,Freedland Stephen J.

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data;Stokes;Prostate Cancer Prostatic Dis,2010

2. International variation in prostate cancer incidence and mortality rates;Center;Eur Urol,2012

3. EAU guidelines on prostate cancer, I: screening, diagnosis, and treatment of clinically localised disease;Heidenreich;Eur Urol,2011

4. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

5. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review;Biomedicines;2024-04-08

2. Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer;New England Journal of Medicine;2023-10-19

3. Surgical androgen deprivation therapy in advanced prostate cancer in patients of African descent: comparison of biochemical efficacy of bilateral total and subcapsular orchidectomy;African Health Sciences;2023-04-11

4. Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis;Frontiers in Oncology;2023-02-09

5. Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer;Journal of Urology;2022-08